tm logo
Trademark Search
DEXTRAMER

View On IC.GC.CA

DEXTRAMER
REGISTERED

on 04 Oct 2024

Last Applicant/ Owned by

IMMUDEX APS

Bredevej 2ADK-2830 Virum

DK

Serial Number

2149894 filed on 04th Nov 2021

Registration Number

TMA1261076 registered on 04th Oct 2024

Registration expiry Date

28th Dec 2029

Correspondent Address

260-10 Research DriveOffice D/EREGINA

SASKATCHEWAN

CA

S4S7J7

DEXTRAMER

Trademark usage description

preparations for pharmaceutical purposes for analysis and treatment of immune cell related diseases, cancer, t-cell lymphoma, t-cell infiltration of s Read More

Classification Information

Class [005]
Preparations for pharmaceutical purposes for analysis and treatment of immune cell related diseases, cancer, T-cell lymphoma, T-cell infiltration of solid tumors and tissue, T-cell diseases in blood, transplantation related diseases and diseases related to immune suppression, autoimmune disease and infectious diseases; pharmaceutical preparations for medical purposes for analysis and treatment of immune cell related diseases, cancer, T-cell lymphoma, T-cell infiltration of solid tumors and tissue, T-cell diseases in blood, transplantation related diseases and diseases related to immune suppression, autoimmune disease and infectious diseases; chemical-pharmaceutical preparations for analysis and treatment of immune cell related diseases, cancer, T-cell lymphoma, T-cell infiltration of solid tumors and tissue, T-cell diseases in blood, transplantation related diseases and diseases related to immune suppression, autoimmune disease and infectious diseases; diagnostic preparations for medical purposes for use in the diagnosis and treatment of immune cell related diseases, cancer, T-cell lymphoma, T-cell infiltration of solid tumors and tissue, T-cell diseases in blood, transplantation related diseases and diseases related to immune suppression, autoimmune disease and infectious diseases; reagents for medical and veterinary purposes for use in the diagnosis and treatment of immune cell related diseases, cancer, T-cell lymphoma, T-cell infiltration of solid tumors and tissue, T-cell diseases in blood, transplantation related diseases and diseases related to immune suppression, autoimmune disease and infectious diseases; chemical preparations for development, use and analysis of cancer vaccines, COVID-19 vaccines, borrelia vaccines, TB vaccines, HIV vaccines and CMV vaccines, and for use in connection with immune related therapy, cancer therapy, for analysis or treatment of immune related diseases, T-cell lymphoma, T-cell infiltration of solid tumors and tissue, and for infectious diseases, and for use in connection with medical analysis, procedures and diagnosis, namely transplantation, immune cell detection, immune cell monitoring, immune cell isolation, immune cell stimulation, immune cell therapy, immune monitoring, and vaccines and T-cell monitoring.

Classification kind code

9

Class [042]
Scientific and technological services and research and design services in the field of immune cell detection, immune cell monitoring, immune cell isolation, immune cell stimulation, immune cell therapy, diagnosis involving analysis of immune cells, medicine and vaccine development; industrial analysis and research services in the field of immune cell detection, immune cell monitoring, immune cell isolation, immune cell stimulation, immune cell therapy, diagnosis involving analysis of immune cells, medicine and vaccine development; basic research and clinical research in the field of immune cell detection, immune cell monitoring, immune cell isolation, immune cell stimulation, immune cell therapy, diagnosis involving analysis of immune cells, medicine and vaccine development.

Classification kind code

9

Mark Details

Serial Number

2149894

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 22
on 21st Mar 2023		Search Recorded
Submitted for opposition 48
on 06th Mar 2023		Agent Changed
Submitted for opposition 256
on 26th Sep 2022		Notification of Possible Opposition Sent
Submitted for opposition 135
on 19th Jan 2022		Amendment to Application
Submitted for opposition 257
on 25th Nov 2021		Designation Notification - Madrid Protocol
Submitted for opposition 1
on 24th Nov 2021		Created
Submitted for opposition 31
on 24th Nov 2021		Formalized
Submitted for opposition 30
on 04th Nov 2021		Filed
Submitted for opposition 238
on 28th Dec 2019		IR Renewed
Submitted for opposition 228
on 28th Dec 2009		International Registration